Product logins

Find logins to all Clarivate products below.


Open Surgery Instruments – Market Insights – United States

The US open surgery instrument market will expand gradually through 2033. This growth will be driven by the continued adoption of advanced, premium-priced technologies, such as direct energy devices and closure devices. However, the market will continue to shift toward MIS, including laparoscopic and robotic-assisted techniques, limiting demand for open surgeries, although the lack of additional reimbursement for robotic-assisted procedures will hinder the pace of RAS procedure volume growth to some extent. Additionally, the rising use of GLP-1 receptor agonists, which is reducing demand for bariatric surgeries, will dampen market growth to some extent.

This Medtech 360 Report provides comprehensive data and analysis on the state of the US open surgery instrument market from 2019 through 2033.

The rise of MIS, particularly robotic-assisted procedures, will have a negative impact on open surgery procedure volumes.

Which procedure types have the highest and lowest open technique penetration amid the growing influence of robotic surgery?

Given the rise of robotic surgery, which open procedures are still growing, and which ones are nearing saturation?

Which technique—open or laparoscopic—is more affected by the rise of robotic surgery?

Emerging technologies and innovative products will grow in popularity at the expense of competing treatment options.

What are the most recent technological innovations in the open surgery instrument market?

How will these innovations affect the efficacy and utilization of procedures in these segments?

What role does strong clinical evidence play in the adoption of new technologies?

GLP-1 receptor agonists have been seeing growing adoption among the US patient population in recent years.

How will the adoption of GLP-1 receptor agonists affect the US open surgery instrument market?

What impact will the rising use of GLP-1 receptor agonists have on bariatric surgery volumes?

The No Surprises Act was enacted in early 2022.

How will this impact emergency open surgery procedure volumes?

Significant changes were made to CPT reimbursement for anterior abdominal hernia repair.

What were the changes introduced by recent CMS coding updates for anterior abdominal hernia repair procedures?

What are the implications of altered CPT reimbursement on hernia repair procedure volumes?

Table of contents


Related Medtech Insights Reports

Report
ENT Devices – Market Insights – United States
The US ENT device market will grow modestly over the forecast period, with the nasal packing and myringotomy/tympanostomy device segments seeing the fastest growth rates. The market will be…
Report
Dialysis Access Treatment Devices – Market Insights – United States
The US dialysis access treatment device market will grow at a moderate rate due to the increasing adoption of innovative products, positive clinical data, and rising ASPs of specific devices like…
Report
Gastrointestinal Endoscopy Devices – Market Insights – United States
The US GI endoscopy device market is projected to experience modest expansion through 2034. The market growth is being driven by supportive treatment and screening guidelines, the growing use of AI…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Japan
The Japanese GI endoscopy device market is projected to experience modest expansion through 2034. This growth is driven by favorable treatment and screening guidelines, as well as an aging…
Report
Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…